Anavex Life Sciences Corp...
11.50
1.03 (9.84%)
At close: Jan 15, 2025, 11:10 AM

Anavex Life Sciences Corp. Statistics

Share Statistics

Anavex Life Sciences Corp. has 84.82M shares outstanding. The number of shares has increased by 4.92% in one year.

Shares Outstanding 84.82M
Shares Change (YoY) n/a
Shares Change (QoQ) 0.02%
Owned by Institutions (%) n/a
Shares Floating 82.12M
Failed to Deliver (FTD) Shares 200
FTD / Avg. Volume 0.01%

Short Selling Information

The latest short interest is 19.69M, so 23.22% of the outstanding shares have been sold short.

Short Interest 19.69M
Short % of Shares Out 23.22%
Short % of Float 23.98%
Short Ratio (days to cover) 10.82

Valuation Ratios

The PE ratio is -11.03 and the forward PE ratio is -14.32.

PE Ratio -11.03
Forward PE -14.32
PS Ratio 0
Forward PS 2.7
PB Ratio 3.94
P/FCF Ratio -15.39
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Anavex Life Sciences Corp..

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.86, with a Debt / Equity ratio of 0.

Current Ratio 8.86
Quick Ratio 8.86
Debt / Equity 0
Total Debt / Capitalization 0
Cash Flow / Debt 0
Interest Coverage 0

Financial Efficiency

Return on equity (ROE) is -0.36% and return on capital (ROIC) is 0%.

Return on Equity (ROE) -0.36%
Return on Assets (ROA) -0.32%
Return on Capital (ROIC) 0%
Revenue Per Employee 0
Profits Per Employee -1.08M
Employee Count 40
Asset Turnover 0
Inventory Turnover 0

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by 74.92% in the last 52 weeks. The beta is 0.6, so Anavex Life Sciences Corp.'s price volatility has been higher than the market average.

Beta 0.6
52-Week Price Change 74.92%
50-Day Moving Average 9.34
200-Day Moving Average 6.08
Relative Strength Index (RSI) 50.02
Average Volume (20 Days) 1.83M

Income Statement

Revenue n/a
Gross Profit 0
Operating Income 0
Net Income -43.00M
EBITDA 0
EBIT n/a
Earnings Per Share (EPS) -0.52
Full Income Statement

Balance Sheet

The company has 132.19M in cash and 0 in debt, giving a net cash position of 132.19M.

Cash & Cash Equivalents 132.19M
Total Debt 0
Net Cash 132.19M
Retained Earnings -336.07M
Total Assets 135.57M
Working Capital 120.26M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -30.81M and capital expenditures 0, giving a free cash flow of -30.81M.

Operating Cash Flow -30.81M
Capital Expenditures 0
Free Cash Flow -30.81M
FCF Per Share -0.37
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

AVXL does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -4.97%
FCF Yield -3.47%
Dividend Details

Analyst Forecast

The average price target for AVXL is $46, which is 339.8% higher than the current price. The consensus rating is "Buy".

Price Target $46
Price Target Difference 339.8%
Analyst Consensus Buy
Analyst Count 3
Stock Forecasts

Stock Splits

The last stock split was on Oct 7, 2015. It was a backward split with a ratio of 1:4.

Last Split Date Oct 7, 2015
Split Type backward
Split Ratio 1:4

Scores

Altman Z-Score 40.06
Piotroski F-Score 2